| Patricia G West, APRN CNM FNP-C WHNPC | |
|
1604 Industrial Park Dr, Paola, KS 66071-9528 | |
| (913) 294-9223 | |
| Not Available |
| Full Name | Patricia G West |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 32 Years |
| Location | 1604 Industrial Park Dr, Paola, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366473746 | NPI | - | NPPES |
| 1366473746 | Medicaid | MO | |
| 100344680C | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 64032 (Kansas) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 5344821 (Kansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Health Partnership Clinic Inc | 6507033867 | 9 |
News Archive
Bioniche Life Sciences In., a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has successfully completed its Australian Offer of 8.6 million CHESS Depositary Instruments at A$1.45 per CDI, raising gross proceeds of A$12.5 million.
Although its been over a decade since endothelial progenitor cells or EPCs, cells that circulate in the blood repairing and replacing the cells that line blood vessels, were identified, the field is still evolving. EPCs are now being studied as biomarkers to assess the risk of future cardiovascular disease and as potential agents for vascular regeneration.
Understanding the cellular building blocks of the brain, including the number and diversity of cell types, is a fundamental step toward understanding brain function. Researchers at the Allen Institute for Brain Science have created a detailed taxonomy of cells in the mouse visual cortex based on single-cell gene expression, identifying 49 distinct cell types in the largest collection of individual adult cortical neurons characterized by gene expression published to date.
Radiation therapy is one of the most widely used cancer treatments, but it often damages normal tissue and can lead to debilitating conditions. A class of drugs known as mammalian target of rapamycin (mTOR) inhibitors can prevent radiation-induced tissue damage in mice by protecting normal stem cells that are crucial for tissue repair, according to a preclinical study published by Cell Press in the September issue of the journal Cell Stem Cell.
› Verified 5 days ago
| Entity Name | Health Partnership Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265785232 PECOS PAC ID: 6507033867 Enrollment ID: O20120127000314 |
News Archive
Bioniche Life Sciences In., a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has successfully completed its Australian Offer of 8.6 million CHESS Depositary Instruments at A$1.45 per CDI, raising gross proceeds of A$12.5 million.
Although its been over a decade since endothelial progenitor cells or EPCs, cells that circulate in the blood repairing and replacing the cells that line blood vessels, were identified, the field is still evolving. EPCs are now being studied as biomarkers to assess the risk of future cardiovascular disease and as potential agents for vascular regeneration.
Understanding the cellular building blocks of the brain, including the number and diversity of cell types, is a fundamental step toward understanding brain function. Researchers at the Allen Institute for Brain Science have created a detailed taxonomy of cells in the mouse visual cortex based on single-cell gene expression, identifying 49 distinct cell types in the largest collection of individual adult cortical neurons characterized by gene expression published to date.
Radiation therapy is one of the most widely used cancer treatments, but it often damages normal tissue and can lead to debilitating conditions. A class of drugs known as mammalian target of rapamycin (mTOR) inhibitors can prevent radiation-induced tissue damage in mice by protecting normal stem cells that are crucial for tissue repair, according to a preclinical study published by Cell Press in the September issue of the journal Cell Stem Cell.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patricia G West, APRN CNM FNP-C WHNPC 405 S Clairborne Rd Ste 2, Olathe, KS 66062-1774 Ph: (913) 730-3661 | Patricia G West, APRN CNM FNP-C WHNPC 1604 Industrial Park Dr, Paola, KS 66071-9528 Ph: (913) 294-9223 |
News Archive
Bioniche Life Sciences In., a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has successfully completed its Australian Offer of 8.6 million CHESS Depositary Instruments at A$1.45 per CDI, raising gross proceeds of A$12.5 million.
Although its been over a decade since endothelial progenitor cells or EPCs, cells that circulate in the blood repairing and replacing the cells that line blood vessels, were identified, the field is still evolving. EPCs are now being studied as biomarkers to assess the risk of future cardiovascular disease and as potential agents for vascular regeneration.
Understanding the cellular building blocks of the brain, including the number and diversity of cell types, is a fundamental step toward understanding brain function. Researchers at the Allen Institute for Brain Science have created a detailed taxonomy of cells in the mouse visual cortex based on single-cell gene expression, identifying 49 distinct cell types in the largest collection of individual adult cortical neurons characterized by gene expression published to date.
Radiation therapy is one of the most widely used cancer treatments, but it often damages normal tissue and can lead to debilitating conditions. A class of drugs known as mammalian target of rapamycin (mTOR) inhibitors can prevent radiation-induced tissue damage in mice by protecting normal stem cells that are crucial for tissue repair, according to a preclinical study published by Cell Press in the September issue of the journal Cell Stem Cell.
› Verified 5 days ago
Megen Male, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 100 Lakemary Dr, Paola, KS 66071 Phone: 913-557-4000 | |
Shana E Pedrow, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2102 Baptiste Drive, Paola, KS 66071 Phone: 913-557-5678 Fax: 913-557-5681 | |
Brooke Lin Ottesen, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2102 Baptiste Dr, Paola, KS 66071 Phone: 913-557-5678 Fax: 913-557-5681 | |
Mrs. Renee Ruth Azzouz, MSN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 100 Lakemary Dr, Paola, KS 66071 Phone: 913-557-4000 Fax: 913-557-4900 | |
Mrs. Barbara Delynn Ford, PMHNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 901 E Miami St, Paola, KS 66071 Phone: 913-340-8600 | |
Kari Alese Gaskell, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1318 Kansas Dr, Paola, KS 66071 Phone: 913-557-5678 Fax: 913-557-5681 | |
Natalie Sue Ketzner, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1318 Kansas Dr, Paola, KS 66071 Phone: 913-557-5678 |